Giuliante, Felice
 Distribuzione geografica
Continente #
EU - Europa 15.038
NA - Nord America 13.703
AS - Asia 9.709
SA - Sud America 1.897
AF - Africa 319
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 40.730
Nazione #
US - Stati Uniti d'America 13.330
IT - Italia 4.985
DE - Germania 4.377
SG - Singapore 4.251
CN - Cina 2.275
BR - Brasile 1.551
SE - Svezia 1.496
VN - Vietnam 966
FR - Francia 913
UA - Ucraina 828
GB - Regno Unito 520
IE - Irlanda 436
IN - India 423
PL - Polonia 333
FI - Finlandia 318
ID - Indonesia 300
JP - Giappone 295
BD - Bangladesh 258
RU - Federazione Russa 230
CA - Canada 197
HK - Hong Kong 181
TR - Turchia 156
AR - Argentina 123
NL - Olanda 107
MX - Messico 102
IQ - Iraq 97
ZA - Sudafrica 92
ES - Italia 84
BE - Belgio 79
AT - Austria 75
MA - Marocco 65
IR - Iran 58
KR - Corea 55
PK - Pakistan 50
EC - Ecuador 47
SA - Arabia Saudita 46
VE - Venezuela 39
JO - Giordania 37
CO - Colombia 36
CZ - Repubblica Ceca 36
RO - Romania 36
AU - Australia 33
CL - Cile 33
AE - Emirati Arabi Uniti 30
EG - Egitto 30
PH - Filippine 30
UZ - Uzbekistan 27
PY - Paraguay 26
CI - Costa d'Avorio 25
DZ - Algeria 25
KE - Kenya 25
LT - Lituania 25
CH - Svizzera 24
IL - Israele 24
MY - Malesia 24
AL - Albania 21
TN - Tunisia 19
GR - Grecia 18
AZ - Azerbaigian 16
CR - Costa Rica 15
UY - Uruguay 15
EU - Europa 14
LU - Lussemburgo 14
NP - Nepal 14
BO - Bolivia 13
PT - Portogallo 13
PE - Perù 11
DK - Danimarca 10
HN - Honduras 10
JM - Giamaica 10
LB - Libano 10
KG - Kirghizistan 9
MD - Moldavia 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
OM - Oman 9
SN - Senegal 9
TH - Thailandia 9
KZ - Kazakistan 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
PA - Panama 7
EE - Estonia 6
ET - Etiopia 5
HR - Croazia 5
HU - Ungheria 5
LK - Sri Lanka 5
NG - Nigeria 5
QA - Qatar 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BH - Bahrain 4
BW - Botswana 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
NI - Nicaragua 4
PR - Porto Rico 4
AM - Armenia 3
Totale 40.660
Città #
Singapore 2.297
Ashburn 1.949
Chandler 1.840
San Jose 1.199
Rome 457
Milan 438
Beijing 437
Dublin 425
Jacksonville 424
New York 378
San Mateo 350
Ho Chi Minh City 341
Los Angeles 306
Nürnberg 277
Tokyo 260
Jakarta 255
Lauterbourg 253
Nanjing 253
Hanoi 242
Hefei 240
Warsaw 237
Boston 233
Wilmington 203
Ann Arbor 199
Dallas 170
Woodbridge 158
Hong Kong 155
Princeton 152
Munich 146
São Paulo 146
Frankfurt am Main 140
Moscow 138
Houston 135
Naples 122
Cattolica 121
Dearborn 113
Redwood City 108
Palermo 107
Marseille 103
Izmir 101
Seattle 101
Hyderabad 99
Santa Clara 95
Helsinki 92
Buffalo 91
The Dalles 87
Fairfield 85
Boardman 83
Chicago 83
Nanchang 82
Brussels 72
Montreal 71
Lawrence 68
Orem 68
Council Bluffs 65
Kent 65
London 64
Augusta 63
Bremen 63
Toronto 63
Shenyang 62
Kraków 61
Denver 58
Shanghai 58
Bari 56
Phoenix 55
Bologna 54
Catania 54
Rio de Janeiro 52
Stockholm 52
Hangzhou 51
Da Nang 50
Atlanta 49
Amsterdam 47
Florence 47
Tianjin 47
Hebei 45
Nuremberg 45
Seoul 45
Turku 45
Mountain View 44
Johannesburg 43
Paris 43
Vienna 43
Brooklyn 42
San Francisco 42
University Park 42
Leawood 41
St Louis 41
Changsha 39
Guangzhou 39
Belo Horizonte 36
Haiphong 35
Chennai 34
Jiaxing 34
Amman 33
Düsseldorf 33
Poplar 33
Turin 33
Dhaka 32
Totale 18.963
Nome #
Complicanze biliari della colecistectomia: la gestione della fase acuta delle lesioni iatrogene della via biliare principale 4.029
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 618
Le lesioni iatrogene della via biliare principale - Associata alla Relazione Biennale su invito al 104° Congresso della Società Italiana di Chirurgia, anno 2002 (Relatore: Gennaro Nuzzo) 540
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 457
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 410
Parenteral nutrition in liver resection 389
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 351
Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence 264
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 255
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 248
Long-term outcome after laparoscopic fenestration of simple liver cysts 246
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 241
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 238
Anatomia del fegato 231
Strong YB-1 expression predicts liver recurrence following resection for colorectal metastases 227
Left hepatectomy for metastatic thrombosis of umbilical vein and left portal vein from renal cell carcinoma 224
External lymphatic fistula after intra-abdominal lymphadenectomy for cancer. Treatment with total parenteral nutrition and somatostatin 224
Prognostic significance of tumor doubling time in mass-forming type cholangiocarcinoma. 222
Liver resection for intrahepatic cholangiocarcinoma 218
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 215
Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver 214
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 213
Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer 212
Hypocholesterolemia in surgical trauma, sepsis, other acute conditions and critical illness 211
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 207
La calcolosi intraepatica primaria. Indicazioni e risultati del trattamento chirurgico resettivo. 205
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 203
Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer 199
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 196
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 195
Plasma bilirubin correlations in non-obstructive cholestasis after partial hepatectomy 193
Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients 193
La calcolosi intraepatica 191
Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients 190
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 188
Hepatic veins in presurgical planning of hepatic resection: what a radiologist should know 187
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 185
Bile duct injury during laparoscopic cholecystectomy: results of an Italian national survey on 56591 cholecystectomies 183
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 181
The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas 181
CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease 180
Giant focal nodular hyperplasia determining Budd-Chiari syndrome: an operative challenge requiring 210 min of liver ischemia 179
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 179
Liver resection for primary intrahepatic stones: a single-center experience 177
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 177
Primary hepatic leiomyosarcoma in a young male after Hodgkin s disease: diagnostic pitfalls and therapeutic challenge 175
Easy quantification of the respiratory and metabolic impact of blood O2-CO2 exchange interactions in critical illness 175
Multidisciplinary management of major bile duct injuries occurred during cholecystectomy 174
Hypocholesterolemia and plasma amino acids in sepsis 174
Intraoperative liver ultrasound still affects surgical strategy for patients with colorectal metastases in the modern era 173
Unexpected gallbladder cancer after laparoscopic cholecystectomy for acute cholecystitis: a worrisome picture 172
Impairment of hepatocellular excretory function, sepsis and liver insufficiency after liver resection (Letter) 171
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 171
Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients 169
Outcomes comparison of Pancreato-Gastrostomy and Isolated Jejunal Loop Pancreato-Jejunostomy following Pancreato-Duodenectomy in patients with soft pancreas and at moderate-high risk for POPF: a retrospective multicenter experience-based analysis 168
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 166
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 166
Prostate apoptosis response-4 is expressed in normal cholangiocytes, is down-regulated in human cholangiocarcinoma, and promotes apoptosis of neoplastic cholangiocytes when induced pharmacologically 165
Reappraisal of surgical indications and approach for liver hemangioma: single-center experience on 74 patients 164
Discrepancy Between Conventional Coagulation Tests and Thromboelastography During the Early Postoperative Phase of Liver Resection in Neoplastic Patients: A Prospective Study Using the New-Generation TEG®6s 161
Complex liver resection for hepatic tumours involving the inferior vena cava 161
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 161
Plasma cholinesterase correlations in acute surgical and critical illness 159
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 159
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 159
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 159
Liver resections for hilar cholangiocarcinoma 158
Severe hypocholesterolemia in surgical patients, sepsis, and critical illness. 156
Analysis of the components of hypertransaminasemia after liver resection 156
Bases fisiológicas da monitorização cardiorrespiratória 155
Plasma cholesterol (CHOL) in critically ill surgical patients 154
An extreme case of Heyde syndrome 153
Radical and palliative surgery of malignant biliary obstruction 153
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 153
Liver resection in advanced age 152
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 152
Risk for laparoscopic fenestration of liver cysts 151
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 151
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 149
Hypophosphatemia (Hypo-P) after liver resections 148
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 147
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 146
Advantages of multidisciplinary management of bile duct injuries occurring during cholecystectomy 146
Pedicle clamping with ischemic preconditioning in liver resection 146
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 146
Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments 145
Role of intraoperative cholangiography in avoiding bile duct injury (Letter) 145
Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum 145
The relationship between plasma albumin, other proteins and variables, and age in the acute phase response after hepatectomy in man 145
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 145
Development and validation of a comprehensive model to predict complications after hepatectomy 145
Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases 144
Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients 142
Complications of laparoscopic cholecystectomy 142
Hepatectomy and plasma cholinesterase evolution 142
Low cholesterol and outcome after hepatectomy 142
Anatomical liver resection of segment 4a en bloc with the caudate lobe 142
Multicentre evaluation of case volume in minimally invasive hepatectomy 142
Sepsis after liver resection: Predisposition, clinical relevance and synergism with liver dysfunction 141
Clinical use of plasma chitotriosidase in severe sepsis 141
Totale 23.188
Categoria #
all - tutte 149.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.649 182 205 75 214 119 101 77 377 138 200 357 604
2022/20235.800 702 688 486 819 345 648 284 593 638 171 257 169
2023/20243.094 165 676 119 288 138 324 380 339 48 128 173 316
2024/20254.726 94 175 397 188 317 148 182 222 651 510 1.006 836
2025/202613.637 1.950 437 800 1.516 2.314 649 2.404 710 882 954 591 430
2026/2027404 404 0 0 0 0 0 0 0 0 0 0 0
Totale 41.267